SCHEMBL13992420

SCHEMBL13992420

C[C@@H](CN)N(CC(=O)C(C)(C)C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14200043 1.00 — —
SCHEMBL13619489 0.78 — —
SCHEMBL13992412 0.75 SLC6A2 (0.42) —
SCHEMBL13596208 0.70 ALOX5 (0.44) —
SCHEMBL13596237 0.70 ALOX5 (0.44) —
SCHEMBL24297510 0.66 POLB (0.32) —
SCHEMBL68248 0.65 CACNA2D1 (0.32) —
SCHEMBL68246 0.65 CACNA2D1 (0.32) —
SCHEMBL9305313 0.65 CACNA2D1 (0.32) —
SCHEMBL13166778 0.65 KMT2A (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7462592-B2 Compositions and methods for polynucleotide delivery NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-12-09 — — US disclosed
Send feedback